Navigation Links
Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Date:4/8/2011

rious medical conditions.  In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential treatment of gout, diseases of the eye (wet age-related macular degeneration and central retinal vein occlusion), and certain cancers.  Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis and other inflammatory conditions, pain, cholesterol reduction, allergic and immune conditions, and cancer.  Additional information about Regeneron and recent news releases are available on Regeneron's web site at www.regeneron.com.

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 16.913 billion (2010), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany.  The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions.  Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide.  Bayer HealthCare has a global workforce of 55.700 employees (Dec 31, 2010) and is represented in more than 100 countries.  Find more information at www.bayerhealthcare.com.

Regeneron Forward-Looking Statements

This news release includes forward-looking statements about Regeneron and its products, development programs, finances, and business, all of which involve a number of risks and uncertainties.  These include,
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
2. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
4. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
5. Regeneron Reports Third Quarter 2009 Financial and Operating Results
6. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
7. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
8. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
9. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
10. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
11. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... Actavis, Inc. (NYSE: ACT ) today ... decision of the U.S. Court of Appeals for the Eleventh ... motion to dismiss the Federal Trade Commission,s lawsuit, FTC ... result of a decision by a 5 to 3 vote.  ... adopted the traditional "rule of reason" as the standard.  ...
(Date:6/17/2013)... TEL AVIV, Israel , June 17, 2013 /PRNewswire/ ... 2013, the Board of Governors of the Israel-U.S. Binational ... $10.95 million in funding for fourteen new projects between ... from BIRD , the projects will access private ... to approximately $33 million. The semi-annual meeting was held ...
(Date:6/17/2013)... NEW ORLEANS , June 17, 2013 /PRNewswire/ ... for new technologies that will help improve medication ... process across its health system. ... a combination of hardware and software that helps ... to dispense and administer medications because of simpler, ...
Breaking Medicine Technology:U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 2U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 2BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 4Ochsner Health System Improves Safety Through Advanced Medication Management Technology 2Ochsner Health System Improves Safety Through Advanced Medication Management Technology 3Ochsner Health System Improves Safety Through Advanced Medication Management Technology 4Ochsner Health System Improves Safety Through Advanced Medication Management Technology 5
... 23 Neurobiological Technologies, Inc. (Nasdaq: NTII ) ("NTI") ... extraordinary dividend of $0.18 per share of common stock, which ... record as of November 30, 2009. The December 9, 2009 ... pursuant to a plan of complete liquidation and dissolution and ...
... Calif., Nov. 23 Advanced Sterilization Products (ASP), ... today the acquisition by its French affiliate, Apsis ... of innovative disinfection processes and technologies to prevent ... disclosed. , Gloster Europe designs and markets ...
Cached Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2
(Date:6/17/2013)... 2013 Essential tremor (ET) is the ... 10 million people in the United States, and millions ... understanding what causes ET, there are no medications specifically ... Tulips for Tremor© is the International Essential Tremor Foundation’s ... and a cure for this life-altering neurological condition. , ...
(Date:6/17/2013)... initiative helped to boost organ donor registration rates, according ... Journal of Transplantation . The findings suggest that social ... variety of problems related to public health in which ... rates in the United States have remained static while ... year. To provide organs to the more than 100,000 ...
(Date:6/17/2013)... 17, 2013 "Do you think you and ... emailing or using your phone even with a hands free ... is just as dangerous as not using a hands free ... you using Facebook, texting, emailing etc." , It ... their reflexes that distract the brain, according to a study ...
(Date:6/17/2013)... 2013 The personal injury trial ... pleased to announce that firm Partners Stephen J. ... ( http://www.blockotoole.com/Attorneys/David-L-Scher.shtml ) will be appearing on hit ... Sunday, June 23, 2013 at 7a.m. Mr. ... Kevin Burke's "Get Active" show, which highlights professionals ...
(Date:6/17/2013)... Angeles (PRWEB) June 17, 2013 According to ... Sunscreen Questions Answered,” as more and more information surfaces about ... sunscreen should become a vital part of one’s skin ... aging and cancer (Go to goo.gl/qTKZQ). , “I agree ... sunscreen,” says Dr. Simon Ourian, Medical Director of Epione Beverly ...
Breaking Medicine News(10 mins):Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:Social media initiative may help increase organ donations 2Health News:Dr. Bonnie Weil Warns Hands Free is Not a Life Saver, It Can Be Just as Much of a Distraction 2Health News:Injury Attorneys Block O'Toole & Murphy, LLP to Appear on Z100 Radio Show This Sunday to Discuss Their Support of St. Jude Children's Research Hospital 2Health News:Skin Care – Answers to Your Sunscreen Questions 2
... BOSTON--A duo of drugs, each targeting a prime survival ... potentially more effective than either drug alone for advanced, ... led by Dana-Farber Cancer Institute investigators. The findings ... at the annual meeting of the American Society of ...
... , FRIDAY, JUNE 3 (HealthDay News) -- People ... a heart attack or serious cardiac event, a new ... is that people with mental illness are 14 percent ... condition, researchers found. Those treatments included coronary artery ...
... June 3 (HealthDay News) -- A new strain of ... has been detected in cows, milk in the United ... the department of veterinary medicine at the University of ... new variant, which is genetically different than existing MRSA ...
... tsunami, tornado or flood strike, among the most vulnerable ... Journal of Emergency Management , researchers in New Zealand ... the age-related needs of adults with regards to the ... Tuohy and Christine Stephens of Massey University in Palmerston ...
... School of Medicine (BUSM) researchers have found that Gabapentin, ... neuropathic pain, seizures and biopolar disease in older and ... anorgasmia, or failure to experience orgasm, than previously reported. ... the American Journal of Geriatric Pharmacotherapy . ...
... nationwide hospital databases, University of Cincinnati (UC) emergency medicine ... treatment with the standard therapy for acute ischemic stroke ... Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the ... the journal Stroke . The study estimates between ...
Cached Medicine News:Health News:Combination antibody therapy shows promise in metastatic melanoma 2Health News:Mental Illness Linked to Greater Risk of Death After Heart Attack 2Health News:Helping the aged during natural disasters 2Health News:Use of clot-busting drug for US stroke patients doubled from 2005 to 2009 2
... design and architectural philosophy of the Kenneth ... stylish, targeted to a discerning customer who ... cues directly from Kenneth Cole New York ... Contemporary crystal tones in multi-laminations craft the ...
... Girl Eyewear extends that easy, breezy, beautiful ... styles, featuring an array of stylish colors, ... ,The collection is designed to target the ... who demands affordability,and high-quality, fashionable frames. The ...
... is a memory metal segment under the Charmant ... better fitting frame that's comfortable yet durable. Small ... or break won't faze CFX because it automatically ... classic to modern to sporty and is coupled ...
... Collection is the world's most extensive ... 100% pure titanium and beta-titanium frames ... superior corrosion resistance. This coupled with ... a collection that is a step ...
Medicine Products: